Biotron (BIT) Stock Statistics & Valuation Metrics

Biotron has a market cap or net worth of AU$6.75M. The enterprise value is AU$1.64M.

Biotron has 2,701,871,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biotron ’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is 288.05%.

The current PE Ratio of Biotron is ―. Biotron ’s PEG ratio is 0.07.

In the last 12 months, Biotron had revenue of 1.81M and earned -318.57K in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was -1.92M and capital expenditures 0.00, giving a free cash flow of -1.92M billion.

Biotron pays an annual dividend of ―, resulting in a dividend yield of ―

Biotron upcoming earnings date is Aug 21, 2026, TBA (Confirmed).

Biotron as a current ratio of 2.23, with Debt / Equity ratio of 0.00%

In the past 12 months, Biotron has paid -1.81M in taxes.

Biotron EV to EBITDA ratio is -3.21, with an EV/FCF ratio of -1.88.

Biotron has AU$1.64M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.64M billion.

Gross margin is 190.21%, with operating margin of -18.68%, and net profit margin of -17.57%.

The average price target for Biotron is ―, which is 11.43% higher than the current price. The consensus rating is ―